Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 141

1.

Vitamin D and Age-Related Macular Degeneration.

Layana AG, Minnella AM, Garhöfer G, Aslam T, Holz FG, Leys A, Silva R, Delcourt C, Souied E, Seddon JM.

Nutrients. 2017 Oct 13;9(10). pii: E1120. doi: 10.3390/nu9101120. Review.

2.

SEVERE CASE OF RENAL COLOBOMA SYNDROME IN LONG-TERM FOLLOW-UP.

Sels L, Dirven W, Devriendt K, Leys A.

Retin Cases Brief Rep. 2020 Winter;14(1):77-81. doi: 10.1097/ICB.0000000000000625.

PMID:
28820764
3.

Six-year outcomes in neovascular age-related macular degeneration with ranibizumab.

Jacob J, Brié H, Leys A, Levecq L, Mergaerts F, Denhaerynck K, Vancayzeele S, Van Craeyveld E, Abraham I, MacDonald K.

Int J Ophthalmol. 2017 Jan 18;10(1):81-90. doi: 10.18240/ijo.2017.01.14. eCollection 2017.

4.

Omega-3 Fatty Acids and Age-Related Macular Degeneration.

Souied EH, Aslam T, Garcia-Layana A, Holz FG, Leys A, Silva R, Delcourt C.

Ophthalmic Res. 2015;55(2):62-9. doi: 10.1159/000441359. Epub 2015 Nov 27. Review.

5.

Early diagnosis and successful treatment of paraneoplastic melanocytic proliferation.

Jansen JC, Van Calster J, Pulido JS, Miles SL, Vile RG, Van Bergen T, Cassiman C, Spielberg LH, Leys AM.

Br J Ophthalmol. 2015 Jul;99(7):943-8. doi: 10.1136/bjophthalmol-2014-305893. Epub 2015 Apr 23.

6.

Ocular features in Alport syndrome: pathogenesis and clinical significance.

Savige J, Sheth S, Leys A, Nicholson A, Mack HG, Colville D.

Clin J Am Soc Nephrol. 2015 Apr 7;10(4):703-9. doi: 10.2215/CJN.10581014. Epub 2015 Feb 3. Review.

7.

Bilateral diffuse uveal melanocytic proliferation with good clinical response to plasmapheresis and treatment of the primary tumor.

Schelvergem KV, Wirix M, Nijs I, Leys A.

Retin Cases Brief Rep. 2015 Spring;9(2):106-8. doi: 10.1097/ICB.0000000000000104.

PMID:
25383840
8.

European survey on the opinion and use of micronutrition in age-related macular degeneration: 10 years on from the Age-Related Eye Disease Study.

Aslam T, Delcourt C, Holz F, García-Layana A, Leys A, Silva RM, Souied E.

Clin Ophthalmol. 2014 Oct 10;8:2045-53. doi: 10.2147/OPTH.S63937. eCollection 2014.

9.

Macular telangiectasia type 2 (MacTel) in a 34-year-old patient.

Nicolai H, Wirix M, Spielberg L, Leys A.

BMJ Case Rep. 2014 Sep 23;2014. pii: bcr2014204802. doi: 10.1136/bcr-2014-204802.

10.

Effect of pegaptanib sodium 0.3 mg intravitreal injections (Macugen) in intraocular pressure: posthoc analysis from V.I.S.I.O.N. study.

Boyer DS, Goldbaum M, Leys AM, Starita C; V.I.S.I.O.N. Study Group.

Br J Ophthalmol. 2014 Nov;98(11):1543-6. doi: 10.1136/bjophthalmol-2013-304075. Epub 2014 Jul 4.

PMID:
24997182
11.

Subconscious manipulation of pain expectation can modulate cortical nociceptive processing.

Lewis GN, Leys A, Rice DA, McNair PJ.

Pain Pract. 2015 Feb;15(2):117-23. doi: 10.1111/papr.12157. Epub 2013 Dec 11.

PMID:
24325269
12.

Immunogammopathies and acquired vitelliform detachments: a report of four cases.

Rusu IM, Mrejen S, Engelbert M, Gallego-Pinazo R, Ober MD, Johnson MW, Leys A, Yannuzzi LA.

Am J Ophthalmol. 2014 Mar;157(3):648-57.e1. doi: 10.1016/j.ajo.2013.11.020. Epub 2013 Dec 7.

PMID:
24321469
13.

Long-term fundus changes in acquired partial lipodystrophy.

Jansen J, Delaere L, Spielberg L, Leys A.

BMJ Case Rep. 2013 Nov 18;2013. pii: bcr2013201218. doi: 10.1136/bcr-2013-201218.

14.

Intravitreal bevacizumab for nonsubfoveal choroidal neovascularization associated with angioid streaks.

Battaglia Parodi M, Iacono P, La Spina C, Berchicci L, Scotti F, Leys A, Introini U, Bandello F.

Am J Ophthalmol. 2014 Feb;157(2):374-377.e2. doi: 10.1016/j.ajo.2013.10.015. Epub 2013 Nov 6.

PMID:
24211865
15.

Real-world variability in ranibizumab treatment and associated clinical, quality of life, and safety outcomes over 24 months in patients with neovascular age-related macular degeneration: the HELIOS study.

Rakic JM, Leys A, Brié H, Denhaerynck K, Pacheco C, Vancayzeele S, Hermans C, Macdonald K, Abraham I.

Clin Ophthalmol. 2013;7:1849-58. doi: 10.2147/OPTH.S49385. Epub 2013 Sep 19.

16.

Traumatic retinopathy presenting as acute macular neuroretinopathy.

Nentwich MM, Leys A, Cramer A, Ulbig MW.

Br J Ophthalmol. 2013 Oct;97(10):1268-72. doi: 10.1136/bjophthalmol-2013-303354. Epub 2013 Jul 12.

PMID:
23853167
17.

Flecked retina, choroidopathy, and retinal pigment epithelial tear in familial pulmonary arterial hypertension.

Torfs S, Leys AM.

Retin Cases Brief Rep. 2013 Summer;7(3):278-84. doi: 10.1097/ICB.0b013e31828eefce.

PMID:
25391124
18.

Retinal pigment epithelial detachments and tears, and progressive retinal degeneration in light chain deposition disease.

Spielberg LH, Heckenlively JR, Leys AM.

Br J Ophthalmol. 2013 May;97(5):627-31. doi: 10.1136/bjophthalmol-2012-302851. Epub 2013 Feb 5.

19.
20.

Micronutrients in age-related macular degeneration.

Aslam T, Delcourt C, Silva R, Holz FG, Leys A, Garcià Layana A, Souied E.

Ophthalmologica. 2013;229(2):75-9. doi: 10.1159/000343708. Epub 2012 Nov 20. Review.

21.

Vertical transmission of macular telangiectasia type 2.

Delaere L, Spielberg L, Leys AM.

Retin Cases Brief Rep. 2012 Summer;6(3):253-7. doi: 10.1097/ICB.0b013e31822477ec.

PMID:
25389724
22.

Diving-related visual loss in the setting of angioid streaks: report of two cases.

Angulo Bocco MI, Spielberg L, Coppens G, Catherine J, Verougstraete C, Leys AM.

Retin Cases Brief Rep. 2012 Summer;6(3):223-7. doi: 10.1097/ICB.0b013e3182247751.

PMID:
25389717
23.

Randomized clinical trial France DMLA2: effect of trimetazidine on exudative and nonexudative age-relatedmacular degeneration.

Cohen SY, Bourgeois H, Corbe C, Chaine G, Espinasse-Berrod MA, Garcia-Sanchez J, Gaudric A, Hullo A, Leys A, Soubrane G, Sahel J.

Retina. 2012 Apr;32(4):834-43. doi: 10.1097/IAE.0b013e31822058a3.

PMID:
21822162
24.

Polypoidal choroidal vasculopathy, diagnosis and management.

Coppens G, Spielberg L, Leys A.

Bull Soc Belge Ophtalmol. 2011;(317):39-44. Review.

PMID:
21560855
25.

Pseudoxanthoma elasticum: clinical, histologic, and genetic studies--a report of two sisters.

Kaimbo DK, Mutosh A, Leys A, Parys-van Ginderdeuren R, Bergen AA.

Skinmed. 2011 Mar-Apr;9(2):119-21.

PMID:
21548520
26.

Chronic central serous choroidopathy with severe visual loss in hyperopic microphthalmic identical twins.

Fabry A, Blanckaert J, Leys A.

GMS Ophthalmol Cases. 2011 Nov 7;1:Doc05. doi: 10.3205/oc000005. eCollection 2011.

27.

Flash photography-induced maculopathy.

Veugelen T, Coutteel C, Leys A.

GMS Ophthalmol Cases. 2011 Sep 15;1:Doc04. doi: 10.3205/oc000004. eCollection 2011.

28.

Visual loss and presumed pseudoxanthoma elasticum confirmed with genetic analysis but not with skin examination and biopsies.

Aerts C, De Keyser C, Leys A.

GMS Ophthalmol Cases. 2011 Sep 15;1:Doc03. doi: 10.3205/oc000003. eCollection 2011.

29.

GMS Ophthalmology Cases - An Open Access Journal.

Kirchhof B, Leys A.

GMS Ophthalmol Cases. 2011 Sep 15;1:Doc01. doi: 10.3205/oc000001. eCollection 2011. No abstract available.

30.

Intravitreal bevacizumab for myopic choroidal neovascularization: 1-year and 2-year results.

Coppens G, Angulo Bocco MI, Spielberg L, Leys A.

Bull Soc Belge Ophtalmol. 2010;(315):39-45.

PMID:
21110509
31.

Posterior reversible encephalopathy syndrome: a rare neurological manifestation in Von Hippel-Lindau disease.

Vanacker P, Vanacker A, Leys A, Thijs V.

Acta Clin Belg. 2010 Jul-Aug;65(4):279-80.

PMID:
20954470
32.

Intravitreal ranibizumab for choroidal neovascularization in angioid streaks.

Mimoun G, Tilleul J, Leys A, Coscas G, Soubrane G, Souied EH.

Am J Ophthalmol. 2010 Nov;150(5):692-700.e1. doi: 10.1016/j.ajo.2010.06.004. Epub 2010 Aug 16.

PMID:
20719301
33.

Treatment of neovascular age-related macular degeneration with a variable ranibizumab dosing regimen and one-time reduced-fluence photodynamic therapy: the TORPEDO trial at 2 years.

Spielberg L, Leys A.

Graefes Arch Clin Exp Ophthalmol. 2010 Jul;248(7):943-56. doi: 10.1007/s00417-009-1256-6. Epub 2010 Mar 4.

PMID:
20204659
34.

Intravitreal bevacizumab for myopic choroidal neovascularization: short-term and 1-year results.

Spielberg L, Leys A.

Bull Soc Belge Ophtalmol. 2009;(312):17-27.

PMID:
19927486
35.

Centripetal retinal capillary proliferation in idiopathic parafoveolar telangiectasis.

Koizumi H, Cooney MJ, Leys A, Spaide RF.

Br J Ophthalmol. 2007 Dec;91(12):1719-20. No abstract available.

36.

Guidance for the treatment of neovascular age-related macular degeneration.

Schmidt-Erfurth UM, Richard G, Augustin A, Aylward WG, Bandello F, Corcòstegui B, Cunha-Vaz J, Gaudric A, Leys A, Schlingemann RO; European Society for Retina Specialists' Guidelines Committee (EURETINA).

Acta Ophthalmol Scand. 2007 Aug;85(5):486-94. Review.

37.

Quality of life in patients with age-related macular degeneration: results from the VISION study.

Leys A, Zlateva G, Shah SN, Patel M.

Eye (Lond). 2008 Jun;22(6):792-8. Epub 2007 Jun 22.

PMID:
17585313
38.

[Pain from complex dressing changes in terminal care].

Devalois B, Gineston L, Leys A.

Soins. 2007 Jan-Feb;(712):50-3. French. No abstract available.

PMID:
17333708
39.

Photodynamic therapy with verteporfin in the treatment of exudative idiopathic polypoidal choroidal vasculopathy.

Mauget-Faÿsse M, Quaranta-El Maftouhi M, De La Marnièrre E, Leys A.

Eur J Ophthalmol. 2006 Sep-Oct;16(5):695-704.

PMID:
17061220
40.

Polypoidal choroidal vasculopathy in tilted disk syndrome and high myopia with staphyloma.

Mauget-Faÿsse M, Cornut PL, Quaranta El-Maftouhi M, Leys A.

Am J Ophthalmol. 2006 Dec;142(6):970-5. Epub 2006 Aug 2.

PMID:
17046703
41.

[The double effect, from a moral principle with to a legislative vision].

Devalois B, Leys A.

Soins. 2006 Sep;(708):36-7. French. No abstract available.

PMID:
17024999
42.

Neovascular growth following photodynamic therapy for choroidal hemangioma and neovascular regression after intravitreous injection of triamcinolone.

Leys AM, Silva R, Inhoffen W, Tatar O.

Retina. 2006 Jul-Aug;26(6):693-7. No abstract available.

PMID:
16829815
43.

Bilateral ocular metastasis from an occult primary melanoma.

Verhulst D, Demaerel P, Damato B, Leys A.

Br J Ophthalmol. 2006 Jul;90(7):922-3. No abstract available.

44.

Verteporfin photodynamic therapy for choroidal neovascularization associated with toxoplasmic retinochoroiditis.

Mauget-Faÿsse M, Mimoun G, Ruiz-Moreno JM, Quaranta-El Maftouhi M, De Laey JJ, Postelmans L, Soubrane G, Defauchy M, Leys A.

Retina. 2006 Apr;26(4):396-403.

PMID:
16603957
45.

Photodynamic therapy for subfoveal classic choroidal neovascularization related to punctate inner choroidopathy (PIC) or presumed ocular histoplasmosis-like syndrome (POHS-like).

Postelmans L, Pasteels B, Coquelet P, Caspers L, Verougstraete C, Leys A, Wirix M, Mauget-Faÿsse M, Quanranta M, Snyers B, Smets E.

Ocul Immunol Inflamm. 2005 Sep-Oct;13(5):361-6.

PMID:
16419421
46.

Photodynamic therapy of subfoveal neovascular membrane in type 2A idiopathic juxtafoveolar retinal telangiectasis.

Snyers B, Verougstraete C, Postelmans L, Leys A, Hykin P.

Am J Ophthalmol. 2004 May;137(5):812-9.

PMID:
15126144
47.

Analysis of the frequent R1141X mutation in the ABCC6 gene in pseudoxanthoma elasticum.

Hu X, Peek R, Plomp A, ten Brink Jt, Scheffer G, van Soest S, Leys A, de Jong PT, Bergen AA.

Invest Ophthalmol Vis Sci. 2003 May;44(5):1824-9.

PMID:
12714611
48.

ABCC6/MRP6 mutations: further insight into the molecular pathology of pseudoxanthoma elasticum.

Hu X, Plomp A, Wijnholds J, Ten Brink J, van Soest S, van den Born LI, Leys A, Peek R, de Jong PT, Bergen AA.

Eur J Hum Genet. 2003 Mar;11(3):215-24.

49.

Subretinal leakage in myopic eyes with a posterior staphyloma or tilted disk syndrome.

Leys AM, Cohen SY.

Retina. 2002 Oct;22(5):659-65. No abstract available.

PMID:
12441740
50.

(Hydroxy)-chloroquine retinal toxicity: two case reports and safety guidelines.

Herman K, Leys A, Spileers W.

Bull Soc Belge Ophtalmol. 2002;(284):21-9.

PMID:
12161987

Supplemental Content

Support Center